Picture of Vaxcyte logo

PCVX — Vaxcyte News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Brief: Vaxcyte And Lonza Expand Collaboration For Global Commercial Manufacturing Of Broad-Spectrum Pneumococcal Conjugate Vaccines(PCVs)

Oct 16 (Reuters) - Vaxcyte Inc  PCVX.O :
    * VAXCYTE AND LONZA EXPAND COLLABORATION FOR GLOBAL
COMMERCIAL
MANUFACTURING OF BROAD-SPECTRUM PNEUMOCOCCAL CONJUGATE VACCINES
(PCVS)
    * VAXCYTE - AGREEMENT TO ESTABLISH GLOBAL COMMERCIAL
MANUFACTURING
CAPACITY FOR CO'S PCV CANDIDATES, VAX-24 & VAX-31, IN ADULT AND
PEDIATRIC POPULATIONS
    * VAXCYTE INC - DESIGN OF DEDICATED MANUFACTURING SUITE IS
NEARLY
COMPLETE, WITH EQUIPMENT INSTALLATION EXPECTED TO BEGIN IN 2024

Source text for Eikon:  ID:nGNX5rjxdX 
Further company coverage:  PCVX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Vaxcyte

See all news